Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-20-009094

Director acquired 1,666 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
ASELAGE STEVE Director 2020-03-01 Grant or award +1,666 $3.00 $4,998 25,092 D
Loading xslF345X03/form4.xml…